Published in Arch Neurol on June 13, 2011
Advances in the development of vaccines for Alzheimer's disease. Discov Med (2013) 0.97
Frontolimbic neural circuitry at 6 months predicts individual differences in joint attention at 9 months. Dev Sci (2012) 0.90
Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities. Pharmacol Ther (2012) 0.85
Anti-amyloid beta to tau - based immunization: Developments in immunotherapy for Alzheimer disease. Immunotargets Ther (2013) 0.78
Evaluation of a DNA Aβ42 Vaccine in Aged NZW Rabbits: Antibody Kinetics and Immune Profile after Intradermal Immunization with Full-Length DNA Aβ42 Trimer. J Alzheimers Dis (2017) 0.76
Alteration in amyloid β42, phosphorylated tau protein, interleukin 6, and acetylcholine during diabetes-accelerated memory dysfunction in diabetic rats: correlation of amyloid β42 with changes in glucose metabolism. Behav Brain Funct (2015) 0.75
Longitudinal change of biomarkers in cognitive decline. Arch Neurol (2011) 2.51
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Translational research in neurology and neuroscience 2010-2011. Arch Neurol (2010) 1.96
Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease. Arch Neurol (2004) 1.78
Translating biomedical research to the bedside: a national crisis and a call to action. JAMA (2003) 1.63
Performance of elderly Native Americans and Caucasians on the CERAD Neuropsychological Battery. Alzheimer Dis Assoc Disord (2005) 1.60
Reporting clinical trials: full access to all of the data. Arch Neurol (2002) 1.39
Genome-wide association studies in Alzheimer disease. Arch Neurol (2008) 1.38
Abeta42 gene vaccine prevents Abeta42 deposition in brain of double transgenic mice. J Neurol Sci (2007) 1.17
FMRI of working memory in patients with mild cognitive impairment and probable Alzheimer's disease. Eur Radiol (2005) 1.09
DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model. JAMA (2009) 1.07
Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease. J Neurol Sci (2005) 1.06
Abeta42 gene vaccination reduces brain amyloid plaque burden in transgenic mice. J Neurol Sci (2006) 1.05
DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation. Cell Mol Neurobiol (2011) 1.02
Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease. Vaccine (2010) 1.00
Advances in the development of vaccines for Alzheimer's disease. Discov Med (2013) 0.97
A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer disease. J Neuroimmunol (2012) 0.94
Can alzheimer's disease and dementias with Lewy bodies be distinguished clinically? J Geriatr Psychiatry Neurol (2003) 0.93
Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA Neurol (2015) 0.84
Active DNA Aβ42 vaccination as immunotherapy for Alzheimer disease. Transl Neurosci (2012) 0.83
Prion proteins: physiological functions and role in neurological disorders. J Neurol Sci (2007) 0.83
Comparison of Alzheimer's disease in Native Americans and Whites. Int Psychogeriatr (2003) 0.82
Dementia diagnosis, treatment, and research with American Indians. Alzheimers Dement (2006) 0.82
Atherosclerosis risk factors in American Indians with Alzheimer disease: preliminary findings. Alzheimer Dis Assoc Disord (2008) 0.79
Neuromics and neurological disease. Arch Neurol (2008) 0.79
Brain MRI, apoliprotein E genotype, and plasma homocysteine in American Indian Alzheimer disease patients and Indian controls. Curr Alzheimer Res (2009) 0.78
Mitochondrial therapy for Parkinson disease. Arch Neurol (2002) 0.78
Increased risk for heterozygotes in recessive Parkinson disease. Arch Neurol (2006) 0.77
Progranulin and tau gene mutations both as cause for dementia: 17q21 finally defined. Arch Neurol (2007) 0.77
Explaining the cause of the amyloid burden in Alzheimer disease. Arch Neurol (2002) 0.76
New presenilin 1 mutation with Alzheimer disease and Lewy bodies. Arch Neurol (2005) 0.76
Treating Alzheimer disease: Time matters. Arch Neurol (2006) 0.76
Metal chelation therapy for Alzheimer disease. Arch Neurol (2003) 0.76
The relationship of cardiovascular risk factors to Alzheimer disease in Choctaw Indians. Am J Geriatr Psychiatry (2011) 0.75
Unreported financial disclosure. Arch Neurol (2009) 0.75
Comment on "American Indians/Alaska natives and dementia". Alzheimer Dis Assoc Disord (2003) 0.75
Unreported financial disclosures. Arch Neurol (2008) 0.75
Genes for movement. Arch Neurol (2004) 0.75
Genes for movement. Arch Neurol (2004) 0.75
Time and memory. Arch Neurol (2002) 0.75
West Nile virus encephalomyelitis in transplant recipients. Arch Neurol (2004) 0.75
Immunotherapy for Alzheimer disease: the promise and the problem. Arch Neurol (2005) 0.75
Pain 2003. Arch Neurol (2003) 0.75
Exercised against dementia. Arch Neurol (2009) 0.75
Notice of incomplete referencing. Arch Neurol (2009) 0.75
Positive potential of fetal nigral implants for Parkinson disease. Arch Neurol (2004) 0.75
The JAMA network journals: new names for the archives journals. Arch Intern Med (2012) 0.75
200 years after Darwin. Arch Neurol (2009) 0.75
At jeopardy: the NIH as we know it. Arch Neurol (2003) 0.75
At jeopardy: the NIH as we know it. Neurorehabil Neural Repair (2003) 0.75
JAMA Neurology Peer Reviewers in 2015. JAMA Neurol (2016) 0.75
The JAMA Network Journals: New Names for the Archives Journals. Arch Otolaryngol Head Neck Surg (2012) 0.75
The JAMA Network journals: new names for the archives journals. Arch Facial Plast Surg (2012) 0.75
Online first all the time and more continuing medical education credit too! Arch Neurol (2012) 0.75
Neuromics. Arch Neurol (2008) 0.75
Expedited publication initiative. Arch Neurol (2011) 0.75
The JAMA Network journals: new names for the archives journals. Arch Surg (2012) 0.75
JAMA Neurology Peer Reviewers in 2015. JAMA Neurol (2016) 0.75
From the genetic code to neuromics. JAMA Neurol (2013) 0.75
Reporting clinical trials: full access to all the data. Mov Disord (2002) 0.75
Reporting clinical trials: full access to all the data. Muscle Nerve (2002) 0.75
Reporting clinical trials: full access to all the data. Brain (2002) 0.75
The JAMA Network Journals: New Names for the Archives Journals. Arch Neurol (2012) 0.75
Cancer of the nervous system: 2010. Arch Neurol (2010) 0.75
The new look of JAMA Neurology! JAMA Neurol (2013) 0.75
The JAMA Network Journals: New Names for the Archives Journals. Arch Ophthalmol (2012) 0.75
The JAMA Network Journals: New Names for the Archives Journals. Arch Gen Psychiatry (2012) 0.75
The JAMA Network Journals: new names for the archives journals. Arch Pediatr Adolesc Med (2012) 0.75
The JAMA Network Journals: new names for the archives journals. Arch Dermatol (2012) 0.75
JAMA Neurology 2013: A New Beginning. Arch Neurol (2012) 0.75
Reporting of randomized clinical trials and other population-based research: a priority of Archives of Neurology. Arch Neurol (2004) 0.75